One of the final­ists for the Pitch 40 com­pe­ti­tion

Oulu-based Finnad­vance has been recent­ly select­ed for the Pitch 40 Com­pe­ti­tion orga­nized by TechAre­na. This pres­ti­gious event brings togeth­er promis­ing star­tups and inno­v­a­tive com­pa­nies to show­case their ground­break­ing tech­nolo­gies. Finnadvance’s inclu­sion high­lights their impact on the biotech land­scape.

TechAre­na, an inter­na­tion­al plat­form for inno­va­tion, entre­pre­neur­ship, and sus­tain­abil­i­ty, brings togeth­er entre­pre­neurs, busi­ness lead­ers, experts, investors, deci­sion-mak­ers, and politi­cians. Their plat­form includes year­ly tech events, a Nordic entre­pre­neur­ship com­pe­ti­tion, and tech-focused news.

The Road Ahead

As Finnad­vance con­tin­ues to refine its OOC tech­nol­o­gy, the phar­ma­ceu­ti­cal indus­try eager­ly awaits its con­tri­bu­tions. With bet­ter pre-clin­i­cal data, reduced costs, and more accu­rate bio­mimet­ic mod­els, Finnad­vance is poised to shape the future of drug devel­op­ment.

Finnad­vance: Pio­neer­ing Organ-on-a-Chip Tech­nol­o­gy for Pre­cise Drug Dis­cov­ery

In the heart of Oulu, Fin­land, a ground­break­ing com­pa­ny is mak­ing waves in phar­ma­ceu­ti­cal research and devel­op­ment. Finnad­vance, found­ed in 2018, has emerged as a trail­blaz­er in the field of organ-on-a-chip tech­nol­o­gy. Their inno­v­a­tive approach promis­es to rev­o­lu­tion­ize drug dis­cov­ery, mak­ing it more pre­cise, effi­cient, and humane.

Source: Finnad­vance